Northern Trust’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Other funds holding BNGO
ACM
Northern Trust's BNGO Position: Q3 2026 in Review
Northern Trust reduced its Bionano Genomics (BNGO) stake by 0.01% in Q3 2026, selling an estimated $3 and leaving 24,559 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4276.
Northern Trust first reported a position in BNGO in Q4 2019 and has held it in 25 quarters since. The position peaked at $15.1M in Q3 2021. 37 funds tracked by Wall St. Rank hold BNGO as of Q3 2026.
- Northern Trust held 24,559 shares of Bionano Genomics worth $38.3K as of Q3 2026.
- Northern Trust sold 2 Bionano Genomics shares in Q3 2026, an estimated $3.
- Bionano Genomics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #4276 holding.
- Northern Trust first reported a position in Bionano Genomics in Q4 2019 and has held it in 25 quarters since.
- Northern Trust's Bionano Genomics position peaked at $15.1M in Q3 2021.
- 37 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.